课题基金 / 基金详情

Immune Compromised Zebrafish for Cell Transplantation

Immune Compromised Zebrafish for Cell Transplantation
用于细胞移植的免疫受损斑马鱼
批准号:
10454455
负责人:
David Michael Langenau
金额:
$17.12万
依托单位国家:
美国
项目类别:
财政年份:
2013
资助国家:
美国
项目状态:
已结题
起止时间:
2013-08-01 至 2022-06-30
关键词:
AdultAllogenicAllograftingAnimal ModelAnimalsB-LymphocytesBloodBlood CellsCD34 geneCancer cell lineCell TransplantationCell physiologyCellsChemicalsCommunicationCommunitiesCommunity MedicineDefectDevelopmentEatingEngraftmentEnsureFeedbackFishesGenerationsGenesGenome engineeringGermGoalsGoldGrowthHeartHomologous TransplantationHumanImmuneInstitutesLabelLaboratoriesLiverMalignant NeoplasmsMature T-LymphocyteMethodsMissionModelingMonoclonal Antibody R24MusMuscle CellsNK-lysinNational Heart, Lung, and Blood InstituteNational Institute of Arthritis and Musculoskeletal and Skin DiseasesNational Institute of Child Health and Human DevelopmentNational Institute of Diabetes and Digestive and Kidney DiseasesNational Institute of Neurological Disorders and StrokeNatural Killer CellsNatural regenerationOpticsPathway interactionsPositioning AttributeProtocols documentationRegenerative MedicineResearchResolutionResourcesSignal TransductionSystemT-LymphocyteTechniquesTimeTissue MicroarrayTissuesTrainingTransgenic OrganismsTransplantationUmbilical Cord BloodUnited States National Institutes of HealthVisualizationWaterWorkXenograft procedureZebrafishcancer cellcancer stem cellcell behaviorcell growthcell typechemical geneticscostcytokinecytotoxicdrug sensitivityexperimental studyfluorescence imaginggenetic approachgenetic regulatory proteinhuman diseasehuman tissuein vivoinduced pluripotent stem cellloss of function mutationmouse modelmutantneovascularizationnext generationnovelpre-clinicalreal-time imagesregenerativeregenerative biologyregenerative cellregenerative tissueself-renewalstem cell functionstem cell self renewalstem cellssuccesstooltranslational impacttransplant modeltreatment responsewebinar

项目摘要

项目成果

David Michael Langenau的其他基金

相似基金

相关文献

中文摘要
翻译
细胞移植到免疫受损的小鼠身上改变了我们对人类疾病和 已被广泛用于评估异种移植中的再生、干细胞自我更新和癌症。 移植环境。尽管老鼠模型有很大的实用价值,但它们并不适合大规模的研究 导致较高的饲养成本,并且不容易在单细胞分辨率下促进移植细胞的直接可视化。 相比之下,斑马鱼价格低廉,可以大量饲养,并且易于规模化 化学遗传方法,化合物可以直接添加到水中。此外,光学上是透明的 免疫缺陷的斑马鱼品系允许大规模细胞移植研究动态成像 单细胞分辨率的荧光标记细胞。尽管取得了这些成功,但还需要做更多的工作来发展 免疫受损斑马鱼作为一种健壮和长期的异种细胞移植模型。长期的 这项应用的目标是开发一种通用的斑马鱼移植模型,用于移植广泛的 斑马鱼、老鼠和人类的再生细胞和癌细胞类型。本应用程序的总体目标是 是为优化再生组织的同种异体移植提供新的免疫缺陷斑马鱼模型 以及人类癌症、ES、iPS和CD34+脐带血细胞的异种移植。我们的理由是 研究表明,斑马鱼的血液发育是高度保守的,而发展斑马鱼移植 模型已经导致了对再生干细胞过程和动态可视化的独特理解 驱动细胞生长的新细胞行为。目标1将开发复合突变体和人源化转基因 斑马鱼用于优化细胞移植。我们将开发缺乏所有T、B和NK细胞的新模型, 包括最近发现的表达细胞毒性血细胞和功能完全丧失的NK-裂解素的突变 Rag2基因突变,这是成熟T和B细胞功能所必需的。我们还将生成 人化斑马鱼,转基因表达支持人类细胞加速生长的因子,包括 人类“不要吃我”信号抑制调节蛋白α(SIRPA)和人类细胞因子。目标2将 利用这些模型评估原位和异种移植,识别具有优势的品系, 长期植入人类癌细胞系、ES和iPS细胞,以及CD34+脐带血细胞。目标3将 完善全球分布和快速传播突变系到斑马鱼、干细胞和 再生医学社区。我们的工作意义重大,因为它将为 社区,促进下一代低成本、高通量的细胞移植模型 移植多种类型的再生细胞。这项工作预计将产生积极的翻译影响, 开发临床前动物模型,便于以更低的成本和 允许化学遗传方法发现与再生和干细胞功能相关的途径。 免疫受损斑马鱼的广泛应用跨越了许多NIH研究所的使命。
英文摘要
Cell transplantation into immune compromised mice has transformed our understanding of human disease and has been used extensively to assess regeneration, stem cell self-renewal, and cancer in the xenograft transplantation setting. Despite their great utility, mouse models are not amenable to large-scale studies due to high husbandry costs and do not easily facilitate direct visualization of engrafted cells at single cell resolution. By contrast, zebrafish are inexpensive, can be reared in large numbers, and are amenable to large-scale chemical genetic approaches where compounds can be added directly to the water. Moreover, optically-clear immune-deficient zebrafish strains have permitted large-scale cell transplantation studies to dynamically image fluorescent-labeled cells at single cell resolution. Despite these successes, more needs to be done to develop immune compromised zebrafish as a robust and long-term xenograft cell transplantation model. The long-term goal of this application is to develop a universal zebrafish transplantation model for engrafting a wide array of regenerative and cancer cell types from zebrafish, mouse, and human. The overall objective of this application is to provide new immune deficient zebrafish models for optimized allograft engraftment of regenerative tissues and xenograft engraftment of human cancer, ES, iPS, and CD34+ cord blood cells. The rationale for our research is that zebrafish blood development is highly conserved and that developing zebrafish transplantation models has already led to unique understanding of regenerative stem cell processes and dynamic visualization of new cell behaviors that drive cell growth. Aim 1 will develop compound mutant and humanized transgenic zebrafish for optimized cell transplantation. We will develop new models that lack all T, B, and NK cells, including mutants in the recently identified NK-lysin expressing cytotoxic blood cells and full loss-of-function mutations in the rag2 gene, which is required for mature T and B cell function. We will also generate humanized zebrafish that transgenically express factors that support elevated growth of human cells, including the human “don’t eat me” signal inhibitory regulatory protein alpha (SIRPa) and human cytokines. Aim 2 will utilize these models for assessing orthotopic and xenograft engraftment, identifying lines that have superior, long-term engraftment of human cancer cell lines, ES and iPS cells, and CD34+ cord blood cells. Aim 3 will refine a system for global distribution and rapid dissemination of mutant lines to the zebrafish, stem cell, and regenerative medicine community. Our work is significant because it will develop a much-needed resource for the community, facilitating the next generation of low-cost, high throughput cell transplantation models to engraft a wide array of regenerative cell types. This work is expected to have a positive translational impact by developing pre-clinical animal models that facilitate direct visualization of engrafted cells at reduced cost and allow chemical genetic approaches to uncover pathways associated with regeneration and stem cell function. Such broad reaching applications for immune compromised zebrafish spans the mission of many NIH institutes.
期刊论文(6)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1084/jem.20162084
发表时间: 2017-12-04
期刊: The Journal of experimental medicine
影响因子: --
作者: [Kasheta M, Painter CA, Moore FE, Lobbardi R, Bryll A, Freiman E, Stachura D, Rogers AB, Houvras Y, Langenau DM, Ceol CJ]
通讯作者: Ceol CJ
Antibody-Peptide Epitope Conjugates for Personalized Cancer Therapy.
用于个性化癌症治疗的抗体-肽表位缀合物。
DOI: 10.1158/0008-5472.can-21-2200
发表时间: 2022
期刊: Cancer research
影响因子: 11.2
作者: [Zhang,Songfa, Yan,Chuan, Millar,DavidG, Yang,Qiqi, Heather,JamesM, Langenbucher,Adam, Morton,LauraT, Sepulveda,Sean, Alpert,Eric, Whelton,LaurenR, Zarrella,DominiqueT, Guo,Mei, Minogue,Eleanor, Lawrence,MichaelS, Rueda,BoR, Spriggs,]
通讯作者: Spriggs,
DOI: 10.1038/s41375-018-0130-0
发表时间: 2018-08
期刊: Leukemia
影响因子: 11.4
作者: [Garcia EG, Iyer S, Garcia SP, Loontiens S, Sadreyev RI, Speleman F, Langenau DM]
通讯作者: Langenau DM
Oncogenic Drivers of Rhabdomyosarcoma Cell State, Cancer Stem Cells and Metastasis
  • 批准号:
    10658091
  • 项目类别:
  • 资助金额:
    $59.87万
  • 财政年份:
    2023
  • 负责人:
    David Michael Langenau
  • 依托单位:
Mechanisms of aggressive Rhabdomyosarcoma.
  • 批准号:
    10560866
  • 项目类别:
  • 资助金额:
    $54.0万
  • 财政年份:
    2023
  • 负责人:
    David Michael Langenau
  • 依托单位:
Developing preclinical xenograft models in zebrafish.
  • 批准号:
    10334672
  • 项目类别:
  • 资助金额:
    $79.46万
  • 财政年份:
    2022
  • 负责人:
    David Michael Langenau
  • 依托单位:
Developing preclinical xenograft models in zebrafish.
  • 批准号:
    10578692
  • 项目类别:
  • 资助金额:
    $79.46万
  • 财政年份:
    2022
  • 负责人:
    David Michael Langenau
  • 依托单位:
海外基金